Debt as of 2Q2018 was Baht 8,194.5 million, increased from Baht 7,338.8 million at the end of 2017, presenting the Net Interest-bearing Debt-to-Equity ratio of 0.64x. As a result, our 2Q2018 EBITDA stood
26,582.8 million, slightly increased by Baht 164.1 million from Baht 26,418.7 million at year-end 2019. The slight increase was mainly because an increase of Cash and Cash Equivalents of Baht 1,714.4 million
end of the first quarter this year stood at 0.98x, an increase from 0.48x in 31 December 2019 1Q 2020 SIGNIFICANT EVENTS New financial reporting standards that became effective in the current period 1
of 2020 increased by 2.8%. • Finance Cost increased to THB 305.2 mm because the Company had loan drawdown from financial institution in the end of Q1 2020 in order to reserve cash for debentures
476.6 million from Baht 26,418.7 million at year-end 2019. The decrease was mainly because of a decrease of Investment in Associates of Baht 1,791.6 million mainly due to TFRS9 adjustment and Net Trade
last year, with the 9M/2023 average funding cost 2.97%, increasing from 2.64% at the end of last year, due to the announcement of the Monetary Policy Committee (MPC) to increase the policy interest rate
equipment rental projects coming in at the end of 2023. In 2022, the Company had a profit from the sale of investments of 108. 6 MB because the Company sold all investments in Genesis Data Center Company
%, increasing from 2.64% at the end of last year, due to the announcement of the Monetary Policy Committee (MPC) to increase the policy interest rate from 0.50% in 2022 to 2.50 as of November 2023 and the rate
gained revenue solely from the medical equipment sales because the dialysis facility had been under construction. The dialysis has been manufactured and distributed around that end of July 2017, resulting
increased in short-term borrowing from financial instituitions in the amount of 7.52 million baht or 12.90% when compare to the end of 2018 which was resulted from more purchase orders for raw materials that